Meta-analysis of propylthiouracil for alcoholic liver disease - A Cochrane Hepato-Biliary Group Review

Liver

Volumn 21, Issue 6, 2001, Pages 398-404

  Rambaldi, A ^a   Gluud, Christian ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Alcoholic; Cochrane; Controlled; Disease; Liver; Meta analysis; Propylthiouracil; Randomised; Systematic review; Trial

Indexed keywords

PLACEBO; PROPYLTHIOURACIL;

ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFECT; ESOPHAGUS VARICES BLEEDING; FATTY LIVER; HEPATIC ENCEPHALOPATHY; HEPATITIS; HUMAN; KIDNEY FAILURE; LEUKOPENIA; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MORTALITY; RISK ASSESSMENT; TREATMENT OUTCOME;

ANTITHYROID AGENTS; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; PROPYLTHIOURACIL; RANDOMIZED CONTROLLED TRIALS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0035184867     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2001.210606.x     Document Type: Article

References (52)

1. Alcoholic liver disease: Natural history, diagnosis, clinical features, evaluation, management, prognosis, and prevention
2. Alcohol-induced hepatic injury in non alcoholic volunteers
3. Liver hypermetabolic state after chronic ethanol consumption: Hormonal interrelationships and pathogenic implications
4. Hepatic vein oxygenation liver blood flow and the rate of ethanol metabolism in recently abstinent patients
5. Clinical pharmacokinetics of antithyroid drugs
6. Treatment of hyperthyroid disease
7. Inhibitory effects of antithyroid drugs on oxygen radical formation in human neutrophils
8. Effect of propylthiouracil on the ethanol-induced increase in liver oxygen consumption in awake rats
9. Effect of antithyroid drugs on hydroxyl radical formation a alpha-1-proteinase inhibitor inactivation by neutrophils: Therapeutic implications
10. Experimental alcohol-induced hepatic necrosis: Suppression by propylthiouracil
11. Enhancement of hypoxic liver damage by ethanol: Involvement of xanthine oxidase and the role of glycolysis
12. Effect of propylthiouracil on liver cell development in the male albino mouse: Protective effect against ethanol-induced alterations
13. Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease
14. Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis
15. Long-term treatment of alcoholic liver disease with propylthiouracil
16. Diagnosis and treatment of alcoholic liver disease in Europe
17. Propylthiouracil for alcoholic liver disease. Cochrane Library (Protocol for a Cochrane Review)
18. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
19. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
20. Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses
21. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
22. Do certain countries produce only positive results? A systematic review of controlled trials
23. Bias in meta-analysis detected by a simple graphical test
24. Short-term therapy with propylthiouracile (PTU) for alcoholic hepatitis (AH). A clinical, biochemical and histological randomized trial about 29 patients
25. Propylthiouracil in acute alcoholic hepatitis
26. Treatment of severe alcoholic hepatitis with propylthiouracil (PTU)
27. Thyroid hormones in alcoholic liver disease. Effect of treatment with 6-n-propylthiouracil
28. Propylthiouracil treatment for alcoholic hepatitis: The case of the missing thirty
29. Chronic propylthiouracil treatment increases survival in patients with alcoholic liver disease
30. Long-term treatment of alcoholic liver disease with propylthiouracil. Influence of drop-out rates and of continued alcohol consumption in a clinical trial
31. Long-term treatment of alcoholic liver disease with propylthiouracil
32. Long term treatment of alcoholic liver disease with propylthiouracil
33. Short-term therapy with propylthiouracil (PTU) for alcoholic hepatitis (AH). A clinical, biochemical and histological randomized trial about 25 patients
34. Vasodilatatory effects of propylthiouracil in patients with alcoholic cirrhosis
35. Acute effects of propylthiouracil on hemodynamics and oxygen content in patients with alcoholic cirrhosis
36. Propylthiouracil-induced fulminant hepatitis: Case report and review of the literature
37. Propylthiouracil-induced severe hepatitis: A case report and review of the literature
38. Sequential liver and bone biochemical changes in hyperthyroidism: Prospective controlled follow-up study
39. Acute intersticial nephritis and fatal Stevens-Johnson syndrome after propylthiouracil therapy
40. Anti-thyroid drug-induced ANCA-associated vasculitis: A case report and review of the literature
41. The swift increase in alcohol metabolism. Inhibition by propylthiouracil
42. Effects of propylthiouracil and methimazole on splanchnic hemodynamics in awake and unrestrained rats
43. What certainty can there be on how much treatments work? Empirical insight from recursive cumulative meta-analyses
44. Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis
45. Glucocorticosteroids are ineffective in alcoholic hepatitis: A meta-analysis adjusting for confounding variables
46. Testosterone and alcoholic cirrhosis. Epidemiologic, pathophysiologic and therapeutic studies in men
47. Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: A multicenter sequential trial
48. Milk thistle (Silybum marianum) for the therapy of liver disease
49. Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: A randomised controlled trial
50. Beneficial effects of polyenylphosphatidylcholine (PPC) in alcoholic and non-alcoholic liver injury
51. Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls
52. Alcoholic liver disease: New insights in pathogenesis lead to new treatments